JNJ vs SGHT · P/E 17, rev $49.37B vs rev $43.1M
Johnson & Johnson (JNJ) versus Sight Sciences Inc (SGHT) — a side-by-side from cached financials, not a winner call.
Johnson & Johnson (JNJ) is a drug manufacturers - general company listed on US. It is led by Joaquin Duato.
Sight Sciences Inc (SGHT) is a medical devices company listed on NASDAQ.
Latest reported JNJ revenue for 2026-06-28 was $49.37B. Net income was $10.77B. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
Latest reported SGHT revenue for 2026-06-30 was $43.1M. Net income was -$17.4M. SGHT currently screens at market cap $273.1M.
JNJ currently screens at market cap $375.37B and trailing P/E 17.4. SGHT currently screens at market cap $273.1M.
Not investment advice. Open the JNJ and SGHT stock pages for the full models.
Not investment advice.